Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Latest videos from the CAR-T Meeting 2021

View all
2:05
CAR-T in DLBCL: 4-year follow-up data from ZUMA-1
Anna Sureda • 9 Feb 2021
3:11
Infection prevention in patients receiving CAR T-cells
Joshua Hill • 10 Feb 2021
6:02
CAR-T vs. BiTEs in B-cell malignancies
Marion Subklewe • 11 Feb 2021
2:02
Research projects within the EN-ACTI2NG program
Hisse M. van Santen • 8 Feb 2021

Lymphoma

View all
1:34
Keynote lectures and BiTE vs CAR-T debate
Nicolaus Kröger • 27 Jan 2021
4:26
CAR-T in myeloma: key players in the therapeutic landscape
Mohamad Mohty • 26 Jan 2021

Leukemia

View all
3:04
ARI-0001 CART19 cells in R/R B-ALL with isolated extramedullary disease
Valentín Ortiz-Maldonado • 3 Feb 2021
4:10
The challenges of CAR T-cell therapy for pediatric B-ALL
Sara Ghorashian • 4 Feb 2021

Multiple Myeloma

View all
4:26
CAR-T in myeloma: key players in the therapeutic landscape
Mohamad Mohty • 26 Jan 2021
4:07
Implementation of CAR T-cell therapy in myeloma: practical and patient-related aspects
Maria Victoria-Mateos • 3 Feb 2021

Policy

View all
2:22
The regulatory process for CAR-T in Europe: EBMT registry & GoCART
Jürgen Kuball • 27 Jan 2021
1:43
Collaboration in the field of cellular therapies
Sofie Terwel • 28 Jan 2021
The content of VJHemOnc is intended for healthcare professionals